Plasma proteomics predicts response to immunotherapy and provides biological insights into tumor-immune system interactions

Watch this presentation by Dr. Marijana Rucevic, Scientific Director, Immuno-Oncology, Olink Proteomics, titled: Plasma proteomics predicts response to immunotherapy and provides biological insights into tumor-immune system interactions. This talk was presented at the SelectScience^® Virtual Cancer and Immunology Research Summit 2021.